Works matching IS 13524585 AND DT 2015 AND VI 21 AND IP 6

Results: 22

Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary.

Published in:

2015

By:

Weinshenker, Brian G

Publication type:

Opinion

Placebo studies should not be undertaken in NMO – Yes.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 689, doi. 10.1177/1352458515579446

By:

Palace, Jacqueline

Publication type:

Article

Placebo studies should not be undertaken in NMO – No.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 691, doi. 10.1177/1352458515579217

By:

Greenberg, Benjamin M

Publication type:

Article

Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.

Published in:

2015

By:

Iorio, Raffaele;
Rindi, Guido;
Erra, Carmen;
Damato, Valentina;
Ferilli, Michela;
Sabatelli, Mario

Publication type:

Case Study

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 678, doi. 10.1177/1352458514567216

By:

Bennett, JL;
de Seze, J;
Lana-Peixoto, M;
Palace, J;
Waldman, A;
Schippling, S;
Tenembaum, S;
Banwell, B;
Greenberg, B;
Levy, M;
Fujihara, K;
Chan, KH;
Kim, HJ;
Asgari, N;
Sato, DK;
Saiz, A;
Wuerfel, J;
Zimmermann, H;
Green, A;
Villoslada, P

Publication type:

Article

High-dose methylprednisolone for multiple sclerosis during lactation: Concentrations in breast milk.

Published in:

2015

By:

Strijbos, E;
Coenradie, S;
Touw, DJ;
Aerden, LAM

Publication type:

Case Study

Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients.

Published in:

2015

By:

De Stefano, Nicola;
Arnold, Douglas L

Publication type:

Editorial

Pactrims Invited Lecture / Ordinary Submission.

Published in:: 2015
Publication type:: Abstract

Dimethyl fumarate associated lymphopenia in clinical practice.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 796, doi. 10.1177/1352458514559299

By:

Longbrake, Erin E;
Cross, Anne H

Publication type:

Article

Brain atrophy in natalizumab-treated patients: A 3-year follow-up.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 749, doi. 10.1177/1352458514556300

By:

Sastre-Garriga, J;
Tur, C;
Pareto, D;
Vidal-Jordana, A;
Auger, C;
Río, J;
Huerga, E;
Tintoré, M;
Rovira, A;
Montalban, X

Publication type:

Article

Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.

Published in:

2015

By:

Artemiadis, AK;
Nikolaou, G;
Kolokythopoulos, D;
Tegos, N;
Terentiou, A;
Triantafyllou, N;
Papanastasiou, I

Publication type:

Case Study

Prevalence of multiple sclerosis among immigrants in Norway.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 695, doi. 10.1177/1352458514554055

By:

Berg-Hansen, Pål;
Moen, Stine M;
Sandvik, Leiv;
Harbo, Hanne F;
Bakken, Inger J;
Stoltenberg, Camilla;
Celius, Elisabeth G

Publication type:

Article

Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 767, doi. 10.1177/1352458514554053

By:

Achiron, Anat;
Givon, Uri;
Magalashvili, David;
Dolev, Mark;
Liraz Zaltzman, Sigal;
Kalron, Alon;
Stern, Yael;
Mazor, Zeev;
Ladkani, David;
Barak, Yoram

Publication type:

Article

The role of cerebellar abnormalities in neuromyelitis optica – a comparison with multiple sclerosis and healthy controls.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 757, doi. 10.1177/1352458514554051

By:

Weier, Katrin;
Eshaghi, Arman;
Magon, Stefano;
Andelova, Michaela;
Radue, Ernst-Wilhelm;
Kappos, Ludwig;
Azimi, Amir Reza;
Sahraian, Mohammad Ali;
Sprenger, Till

Publication type:

Article

Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 703, doi. 10.1177/1352458514551780

By:

Simon, KC;
Schmidt, H;
Loud, S;
Ascherio, A

Publication type:

Article

Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 718, doi. 10.1177/1352458514551594

By:

Ghassemi, Rezwan;
Brown, Robert;
Banwell, Brenda;
Narayanan, Sridar;
Arnold, Douglas L.

Publication type:

Article

Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 726, doi. 10.1177/1352458514551456

By:

Chiarini, M;
Sottini, A;
Bertoli, D;
Serana, F;
Caimi, L;
Rasia, S;
Capra, R;
Imberti, L

Publication type:

Article

Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 710, doi. 10.1177/1352458514551454

By:

Hyun, Jae-Won;
Kim, Su-Hyun;
Huh, So-Young;
Kim, Woojun;
Yun, Junglim;
Joung, AeRan;
Sato, Douglas Kazutoshi;
Fujihara, Kazuo;
Kim, Ho Jin

Publication type:

Article

Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 735, doi. 10.1177/1352458514551453

By:

Ahn, Jeeyoon Jennifer;
O’Mahony, Julia;
Moshkova, Marina;
Hanwell, Heather E;
Singh, Hargurinder;
Zhang, Monan Angela;
Marrie, Ruth Ann;
Bar-Or, Amit;
Sadovnick, Dessa A;
Dunn, Shannon E;
Banwell, Brenda L

Publication type:

Article

Relapses in patients treated with fingolimod after previous exposure to natalizumab.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 786, doi. 10.1177/1352458514549404

By:

Comi, G;
Gold, R;
Dahlke, F;
Sinha, A;
von Rosenstiel, P;
Tomic, D;
Kappos, L

Publication type:

Article

Significant clinical worsening after natalizumab withdrawal: Predictive factors.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 780, doi. 10.1177/1352458514549401

By:

Vidal-Jordana, A;
Tintoré, M;
Tur, C;
Pérez-Miralles, F;
Auger, C;
Río, J;
Nos, C;
Arrambide, G;
Comabella, M;
Galán, I;
Castilló, J;
Sastre-Garriga, J;
Rovira, A;
Montalban, X

Publication type:

Article

Changing definitions of euphoria in multiple sclerosis: A short report.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 776, doi. 10.1177/1352458514549400

By:

Duncan, Amy;
Malcolm-Smith, Susan;
Ameen, Ozayr;
Solms, Mark

Publication type:

Article